Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Christoph Wanner
ResearcherPublications, citations & collaboration network
Christoph Wanner is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,289 works, 104,723 citations, an h-index of 135 and an i10-index of 692.
1,289
Works
104,723
Citations
135
h-index
692
i10-index
How has Christoph Wanner's publication output changed over time?
ScholarIQpublication output · 2005–2024
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2024.
1
1
1
1
1
1
1
1
1
1
2005200720152016201820202021202220232024
What are the most-cited papers on Christoph Wanner?
ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno, Bernard Cosyns, Carolyn Crawford, Constantinos H. Davos, Ileana Désormais, Emanuele Di Angelantonio, Oscar H. Franco, Sigrun Halvorsen, Richard Hobbs, Monika Hollander, Ewa A. Jankowska, Matthias Michal, Simona Sacco, Naveed Sattar, Lâle Tokgözoğlu, Serena Tonstad, Konstantinos Tsioufis, Ineke van Dis, Isabelle C. Van Gelder, Christoph Wanner, Bryan Williams, ESC Scientific Document Group, Guy De Backer, Vera Regitz‐Zagrosek, Anne Hege Aamodt, Magdy Abdelhamid, Victor Aboyans, Christian Albus, Riccardo Asteggiano, Magnus Bäck, Michael A. Borger, Carlos Brotons, Jelena Čelutkienė, Renata Cífková, Maja Čikeš, Francesco Cosentino, Nikolaos Dagres, Tine De Backer, Dirk De Bacquer, Victoria Delgado, Hester M. den Ruijter, Paul Dendale, Heinz Drexel, Volkmar Falk, Laurent Fauchier, Brian A. Ference, Jean Ferrières, Marc Ferrini, Miles Fisher, Danilo Fliser, Zlatko Fras, Dan Gaiță, Simona Giampaoli, Stephan Gielen, Ian Graham, Catriona Jennings, Torben Jørgensen, Alexandra Kautzky‐Willer, Maryam Kavousi, Wolfgang Köenig, А. О. Конради, Dipak Kotecha, Ulf Landmesser, Madalena Lettino, Basil S. Lewis, Aleš Linhart, Maja‐Lisa Løchen, Konstantinos Makrilakis, Giuseppe Mancia, Pedro Marques‐Vidal, John W. McEvoy, Paul McGreavy, Béla Merkely, Lis Neubeck, Jens Cosedis Nielsen, Joep Perk, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Nana Goar Pogosova, Eva Prescott, Kausik K. Ray, Željko Reiner, Dimitrios Richter, Lars Rydén, Е. V. Shlyakhto, Marta Sitges, Miguel Sousa‐Uva, Isabella Sudano, Monica Tiberi, Rhian M. Touyz
European Heart Journal. 20216,449 CitationsOPEN ACCESS
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart Pocock, Peter E. Carson, James L. Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Alcides Bocchi, Michael Böhm, Dong‐Ju Choi, Vijay Chopra, Eduardo Chuquiure‐Valenzuela, Nadia Giannetti, Stefan Janssens, Jian Zhang, José Ramón González‐Juanatey, Sanjay Kaul, Hans‐Peter Brunner‐La Rocca, Béla Merkely, Stephen J. Nicholls, Sergio V. Perrone, Ileana L. Piña, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie‐France Seronde, Jindřich Špinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faı̈ez Zannad
New England Journal of Medicine. 20205,122 CitationsOPEN ACCESS
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Bernard Zinman
New England Journal of Medicine. 20163,655 CitationsOPEN ACCESS
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, Michel Burnier, Guıdo Grassı, Andrzej Januszewicz, María Lorenza Muiesan, Konstantinos Tsioufis, Enrico Agabiti‐Rosei, Engi Algharably, Michel Azizi, Athanase Bénétos, Claudio Borghi, Jana Brguljan Hitij, Renata Cífková, António Coca, Véronique Cornelissen, Justin Cruickshank, Pedro Cunha, A.H. Jan Danser, Rosa de Pinho, Christian Delles, Anna F. Dominiczak, Maria Dorobanţu, Michalis Doumas, María S. Fernández‐Alfonso, Jean‐Michel Halimi, Zoltán Járai, Bojan Jelaković, Jens Jordan, Tatiana Kuznetsova, Stéphane Laurent, Dragan Lović, Empar Lurbe, Felix Mahfoud, Athanasios Manolis, Marius Miglinas, Krzysztof Narkiewicz, Teemu Niiranen, Paolo Palatini, Gianfranco Parati, Atul Pathak, Alexandre Persu, Jorge Polónia, Josep Redón, Pantelis Sarafidis, Roland E. Schmieder, Bart Spronck, Stella Stabouli, George S. Stergiou, Stefano Taddei, Costas Thomopoulos, Maciej Tomaszewski, Philippe van de Borne, Christoph Wanner, Thomas Weber, Bryan Williams, Zhen‐Yu Zhang, Sverre E. Kjeldsen
Journal of Hypertension. 20233,219 CitationsOPEN ACCESS
Related on ScholarIQ
Universitätsklinikum Würzburg
Institution
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Paper
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Paper
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Paper
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Paper
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Paper